A ReaL World Study of DS-8201

Active, not recruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions

Breast Cancer MetastaticTreatment Efficacy

Trial Locations (1)

Fudan University Shanghai Cancer center, Shanghai

All Listed Sponsors

lead

Fudan University

OTHER

NCT06945224 - A ReaL World Study of DS-8201 | Biotech Hunter | Biotech Hunter